IL-6 and its receptors in coronary artery disease and acute myocardial infarction
Authors:
- Daniel R. AndersonDADaniel R. Anderson
- Joseph T. PoteruchaJPJoseph T. Poterucha
- Ted R. MikulsTMTed R. Mikuls
- Michael J. DuryeeMichael J. Duryee
- Robert P. GarvinRGRobert P. Garvin
- Lynell W. KlassenLKLynell W. Klassen
- Scott W. ShurmurSSScott W. Shurmur
- Geoffrey M. ThieleGTGeoffrey M. Thiele
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The pro- and anti-inflammatory properties of the cytokine interleukin-6Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Executive Summary: Heart Disease and Stroke Statistics—2010 UpdateCirculation, 2010
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Inflammation in atherosclerosisNature, 2002
- Innate and Adaptive Immunity in the Pathogenesis of AtherosclerosisCirculation Research, 2002
- Circulating soluble gp130, soluble IL-6R, and IL-6 in patients undergoing cardiac surgery, with or without extracorporeal circulationEuropean Journal of Cardio-Thoracic Surgery, 2000
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Prediction of Coronary Heart Disease Using Risk Factor CategoriesCirculation, 1998
- Elevated plasma interleukin-6 levels in patients with acute myocardial infarctionAmerican Heart Journal, 1993
- Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130Blood, 1993